Health Care [ 12/12 ] | Health Care Equipment & Supplies [ 44/74 ]
NASDAQ | Common Stock
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.
The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease.
The company was founded in 2017 and is based in Gaithersburg, Maryland.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Sep 30, 23 | -0.21 | - |
| Jun 30, 23 | -0.24 | - |
| Apr 25, 23 | -0.11 | - |
| Nov 7, 22 | -0.10 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 65.00 K Increased by +N/A% | -1.25 M Decreased by -63.85% | Decreased by -1.93 K% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -1.48 M Decreased by -90.79% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 10.00 K Increased by +N/A% | -695.52 K Decreased by -22.81% | Decreased by -6.96 K% Decreased by N/A% |
| Dec 31, 22 | 10.00 K Increased by +N/A% | -695.52 K Decreased by -331.84% | Decreased by -6.96 K% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -764.69 K Decreased by -314.54% | Decreased by N/A% - |
| Jun 30, 22 | 0.00 Decreased by N/A% | -775.92 K Decreased by -308.96% | Decreased by N/A% - |
| Mar 31, 22 | 0.00 - | -566.36 K - | Decreased by N/A% - |
| Dec 31, 21 | 0.00 - | -161.06 K - | Decreased by N/A% - |